OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Discovering Tuberosin and Villosol as Potent and Selective Inhibitors of AKT1 for Therapeutic Targeting of Oral Squamous Cell Carcinoma
Mohd Adnan, Deeba Shamim Jairajpuri, Muskan Chaddha, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 7, pp. 1083-1083
Open Access | Times Cited: 11
Mohd Adnan, Deeba Shamim Jairajpuri, Muskan Chaddha, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 7, pp. 1083-1083
Open Access | Times Cited: 11
Showing 11 citing articles:
Discovering potential ERK1 inhibitors from natural products for therapeutic targeting of Alzheimer's disease
Mohammad Taufeeq, Arunabh Choudhury, Afzal Hussain, et al.
Journal of Alzheimer s Disease (2025)
Closed Access | Times Cited: 1
Mohammad Taufeeq, Arunabh Choudhury, Afzal Hussain, et al.
Journal of Alzheimer s Disease (2025)
Closed Access | Times Cited: 1
Identifying potential inhibitors of phosphatidylinositol 4,5-bisphosphate 3-kinase: Molecular dynamic insights into the interaction and inhibitory mechanism
Taj Mohammad, Afzal Hussain, Mohamed F. Alajmi, et al.
Chemical Physics Impact (2024) Vol. 8, pp. 100458-100458
Open Access | Times Cited: 6
Taj Mohammad, Afzal Hussain, Mohamed F. Alajmi, et al.
Chemical Physics Impact (2024) Vol. 8, pp. 100458-100458
Open Access | Times Cited: 6
Identification of High-Affinity Inhibitors of TANK-Binding Kinase 1 (TBK1): A Promising Frontier for Controlling Inflammatory Signaling in Cancer
Deeba Shamim Jairajpuri, Taj Mohammad, Afzal Hussain, et al.
Discovery Medicine (2024) Vol. 36, Iss. 180, pp. 129-129
Open Access | Times Cited: 4
Deeba Shamim Jairajpuri, Taj Mohammad, Afzal Hussain, et al.
Discovery Medicine (2024) Vol. 36, Iss. 180, pp. 129-129
Open Access | Times Cited: 4
Probing Baicalin as potential inhibitor of Aurora kinase B: A step towards lung cancer therapy
Saba Noor, Arunabh Choudhury, Ali Raza, et al.
International Journal of Biological Macromolecules (2023) Vol. 258, pp. 128813-128813
Closed Access | Times Cited: 8
Saba Noor, Arunabh Choudhury, Ali Raza, et al.
International Journal of Biological Macromolecules (2023) Vol. 258, pp. 128813-128813
Closed Access | Times Cited: 8
Identification of Potential Bioactive Phytochemicals for the Inhibition of Platelet-Derived Growth Factor Receptor β: An integrated docking and MD simulation approach
Insan Habib, Md Nayab Sulaimani, Afzal Hussain, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Insan Habib, Md Nayab Sulaimani, Afzal Hussain, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Bioprospecting of potential inhibitors of 5alpha reductase 2 inhibitors from relevant ethno-pharmacological plants via in silico techniques
Patrick O. Sakyi, Selina Ama Saah, Prince Baddor, et al.
Scientific African (2024) Vol. 25, pp. e02264-e02264
Open Access | Times Cited: 1
Patrick O. Sakyi, Selina Ama Saah, Prince Baddor, et al.
Scientific African (2024) Vol. 25, pp. e02264-e02264
Open Access | Times Cited: 1
Puerarin: An Anticancer and Anti-Inflammatory Agent
Harinder R. Singh, Priyanka Kriplani, Sweta Kamboj, et al.
Recent Patents on Anti-Cancer Drug Discovery (2023) Vol. 19, Iss. 1, pp. 18-36
Closed Access | Times Cited: 2
Harinder R. Singh, Priyanka Kriplani, Sweta Kamboj, et al.
Recent Patents on Anti-Cancer Drug Discovery (2023) Vol. 19, Iss. 1, pp. 18-36
Closed Access | Times Cited: 2
Association of KRAS Mutation and Gene Pathways in Colorectal Carcinoma: A Transcriptome- and Methylome-Wide Study and Potential Implications for Therapy
Farzana Jasmine, Armando Almazan, Yuliia Khamkevych, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8094-8094
Open Access
Farzana Jasmine, Armando Almazan, Yuliia Khamkevych, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8094-8094
Open Access
In silico investigation of potential interleukin-8 (IL-8) and Cathelicidin (LL-37) inhibitors for rosacea treatment
Taufik Muhammad Fakih, Deis Hikmawati, Endang Sutedja, et al.
Pharmacia (2024) Vol. 71, pp. 1-12
Open Access
Taufik Muhammad Fakih, Deis Hikmawati, Endang Sutedja, et al.
Pharmacia (2024) Vol. 71, pp. 1-12
Open Access
Identification of potential bioactive phytochemicals for the inhibition of platelet-derived growth factor receptor β: a structure-based approach for cancer therapy
Insan Habib, Md Nayab Sulaimani, Deeba Shamim Jairajpuri, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access
Insan Habib, Md Nayab Sulaimani, Deeba Shamim Jairajpuri, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access
Discovery of novel bioactive compounds in Catharanthus roseus exhibiting anti-angiogenic activity against VEGFR-2 TKD for Glioblastoma tumour growth suppression
Anna Senrung, Durgesh Kumar, Nidhi Bhardwaj, et al.
(2024) Vol. 11, Iss. 2
Open Access
Anna Senrung, Durgesh Kumar, Nidhi Bhardwaj, et al.
(2024) Vol. 11, Iss. 2
Open Access
